Scholars Central

Research articlePublished 20 Jan 2020

Is Gender Associated to Extended Cardiac Monitoring after First Dose of Fingolimod and Level of Satisfaction with the Monitoring Experience in Relapsing-Remitting Multiple Sclerosis Patients? A Post-hoc Analysis of the BEAT Study

Authors: Delia Colombo, Emanuela Zagni, Alessandra Ori, Nicola Montano, Giuseppe De Angelis, Emilio Vanoli

Journal of Multiple Sclerosis

Volume 7 · Issue 2 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: Fingolimod, a second-line therapy for relapsing-remitting multiple sclerosis, may cause transitory effects on heart rate and atrioventricular conduction that may result in bradycardia and atrioventricular blocks, mainly following first administration; an ECG monitoring for at least 6 hours is therefore recommended, to be extended in case of bradycardia. The BEAT study showed that the dominance of cardiac vagal modulation, though not representing a risk factor for rhythm complications, can help identifying patients with higher probability to require extended monitoring. Methods: This is a post-hoc analysis of the BEAT study, aimed at assessing the association between gender and need of extension of the ECG and gender differences in patients’ satisfaction with drug administration and monitoring experience. Results: Of the 625 patients evaluated in the BEAT study (67% were women), only 45 (7.2%; 95% CI: 5.3%; 9.5%) required an extended monitoring. Gender differences emerged in the assumption of drugs altering heart rate or atrioventricular conduction (6.4% of females vs. 0.5% of males, Chi-square test p-value=0.001) and in the sympathovagal balance status (median (interquartile range) RR LF/HF in women: 3.3 (1.3-7.4) respectively vs. 4.5 (2.1-10.2) in men, Wilcoxon test p-value=0.001). However, keeping constant the effect of these variables, no association emerged between sex and early ECG abnormalities requiring a prolongation of post-first dose monitoring. Our specifically developed satisfaction score showed a higher level of satisfaction with the overall care experience in women than in men (beta female vs. male=1.69 points) and women perceived a greater favorable impact of the drug on their daily living than man (median of ‘impact of treatment’ item in males and females 7.0 and 2.0, respectively, Wilcoxon test p-value=0.005). Conclusion: No association emerged between sex and early ECG response to fingolimod administration requiring extended cardiac monitoring. More women than men reported a higher level of satisfaction with drug administration and monitoring procedures.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Multiple Sclerosis.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Multiple Sclerosis
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Delia Colombo”
  • BylineArticles whose byline prints “Emanuela Zagni”
  • BylineArticles whose byline prints “Alessandra Ori”
  • BylineArticles whose byline prints “Nicola Montano”
  • BylineArticles whose byline prints “Giuseppe De Angelis”
  • BylineArticles whose byline prints “Emilio Vanoli”